Unlock instant, AI-driven research and patent intelligence for your innovation.

Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring

A ganglioside and annexin technology, applied in biological testing, biochemical equipment and methods, microbial measurement/testing, etc., can solve problems such as high heterogeneity

Pending Publication Date: 2020-11-13
AGENCY FOR SCI TECH & RES +1
View PDF16 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the species and origin of many of these particles in body fluids are unknown and are presumed to be highly heterogeneous

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring
  • Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring
  • Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0164] Microparticle preparation

[0165] CTB or Annexin V-bound microparticles can be prepared from plasma (or other fluid) by the following protocol:

[0166] 10 μL plasma was treated with 0.1 μg biotinylated cholera toxin subunit B (CTB) (SBL Vaccin AB) or 0.1 μg biotinylated annexin V (AV) (BioVision) in 100 μL, pH 7.4 PBS at Incubate at 37°C for 1 hour with shaking at 800 rpm. At the same time, 100 μL M-280 streptavidin (Invitrogen) was washed three times with 100 μL PBS. After the last wash, the plasma-CTB or plasma-AV reaction mixture was added to the washed beads and incubated for 30 min with shaking at 800 rpm. The beads were fixed with a magnet and the supernatant was removed. The beads were then washed three times with 200 μl of PBS, and the eluate was removed after each fixation of the beads with a magnet.

[0167] Ratio of GM1 ganglioside microparticle polypeptide to annexin V microparticle polypeptide

[0168] The ratio of GM1 ganglioside particle polypept...

Embodiment 1

[0174] Example 1: Enrichment of CD9+ microparticles from serum of normal individuals

[0175] In this study, the inventors determined for the first time whether CTB binds to CD9+ microparticles in serum. Due to the lack of CTB-bound CD9, the inventors determined the sedimentation density of serum CD9+ microparticles in a sucrose density gradient and found that the sedimentation density of CD9 was higher in serum than in exosomes.

[0176] The lack of CTB binding and the high sedimentation density suggest that CD9+ microparticles are apoptotic bodies. This was subsequently confirmed by the binding of serum CD9 to Annexin V.

Embodiment 2

[0177] Example 2: Materials and Methods - Molecular Sieve Chromatography

[0178] 2mL 2B resin (Sigma Aldrich, Cat no. 2B300) was packed into a spin column (Bio-Rad, Cat no. 732-6008) and centrifuged at 800 g for 1 min. The supernatant was removed and rinsed by adding 1 mL of phosphate-buffered saline (PBS), followed by centrifugation at 800 g for 1 min. Subsequently, 1 mL of human serum was loaded and centrifuged at 800 g for 1 min.

[0179] The flow through was collected and the process was repeated three times with 1 mL of PBS each time. Three eluate fractions were collected. Take 20 μl of each fraction and separate on 4-12% SDS / polyacrylamide gel. The resulting gel was processed with SilverQuest TM Silver Staining Kit (Invitrogen, Carlsbad, CA) staining, or electrotransfection onto nitrocellulose membranes. The membrane was labeled with mouse anti-human CD9 antibody diluted 1:50, followed by HRP-conjugated donkey anti-mouse IgG antibody diluted 1:1250.

[0180] Al...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

We describe a method of monitoring the state of a cell, tissue, organ or organism. The method comprises establishing, for a sample of microparticles from the cell, tissue, organ or organism, a ratio.The ratio is of a selected polypeptide in microparticles which comprise GMl gangliosides, preferably which bind to Cholera Toxin B (CTB) (''GMl ganglioside microparticle polypeptide'') to the selectedpolypeptide in microparticles which comprise exposed phosphotidylserine, preferably which bind to Annexin V (''Annexin V microparticle polypeptide''). The GMl ganglioside microparticle polypeptide toAnnexin V microparticle polypeptide ratio so established may be indicative of the state of the cell, tissue, organ or organism.

Description

[0001] This application is a divisional application, the filing date of the original application is November 30, 2012, the application number is 201280066933.X, and the name is "Particulate Polypeptides of GM1 Ganglioside and Annexin V for Biological Detection" Proportion". technical field [0002] The present invention relates to the fields of medicine, cell biology, molecular biology and genetics. The present invention relates to the field of medicine. [0003] In particular, the present invention relates to methods of detecting physiological and pathological states of cells, tissues, organs or organisms. The invention also relates to the diagnosis and treatment of diseases such as cancer. [0004] See US patent applications 60 / 713,992, 12 / 065,549, 12 / 065,551, 60 / 878,222, 12 / 377,398, 61 / 066,671, 61 / 227,865, and 61 / 257,121. Reference is also made to International Patent Applications PCT / GB2005 / 003206, PCT / SG2006 / 000233, PCT / SG2006 / 000232, PCT / SG2007 / 000257 and PCT / SG2009 / 0...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N1/28G01N1/34G01N30/06G01N30/08G01N33/68C12Q1/02
CPCG01N33/5091G01N33/6893G01N2800/32G01N2800/368G01N2405/10G01N33/689G01N2800/52G01N2333/47G01N33/6872G01N2800/7028
Inventor 林赛娟陈国贤
Owner AGENCY FOR SCI TECH & RES